IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MAGAGNOLI, LORENZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.570
EU - Europa 1.543
NA - Nord America 1.351
SA - Sud America 142
AF - Africa 34
OC - Oceania 6
Totale 4.646
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.298
IT - Italia 808
SG - Singapore 516
CN - Cina 461
VN - Vietnam 131
GB - Regno Unito 129
BD - Bangladesh 126
HK - Hong Kong 123
NL - Olanda 114
RU - Federazione Russa 113
BR - Brasile 108
DE - Germania 95
SE - Svezia 79
FR - Francia 69
IN - India 64
FI - Finlandia 33
ID - Indonesia 33
CA - Canada 30
IE - Irlanda 27
JP - Giappone 25
KR - Corea 18
AR - Argentina 15
IQ - Iraq 13
TR - Turchia 13
AT - Austria 11
BE - Belgio 10
CI - Costa d'Avorio 10
MX - Messico 10
PL - Polonia 10
ZA - Sudafrica 9
ES - Italia 8
PK - Pakistan 8
IR - Iran 7
EC - Ecuador 6
PH - Filippine 6
CH - Svizzera 5
MA - Marocco 5
PE - Perù 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
IL - Israele 4
RO - Romania 4
RS - Serbia 4
VE - Venezuela 4
CL - Cile 3
CR - Costa Rica 3
HU - Ungheria 3
MY - Malesia 3
NI - Nicaragua 3
AL - Albania 2
BY - Bielorussia 2
DZ - Algeria 2
HN - Honduras 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CG - Congo 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
JM - Giamaica 1
LT - Lituania 1
LV - Lettonia 1
NP - Nepal 1
PA - Panama 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
SD - Sudan 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 4.646
Salva come PNG Salva come JPEG
Città #
Singapore 251
Ashburn 203
Milan 119
Hong Kong 106
Hefei 104
Dallas 101
Southend 97
San Jose 82
Beijing 74
Santa Clara 71
Los Angeles 66
Rome 59
Chandler 52
Council Bluffs 45
Frankfurt am Main 42
Ho Chi Minh City 39
Hanoi 38
Bengaluru 36
New York 34
Chicago 31
Fairfield 29
Buffalo 27
Dublin 27
Moscow 27
Turin 27
Lauterbourg 25
Jakarta 22
Boardman 19
Bologna 18
Seattle 18
Guangzhou 16
Phoenix 16
Naples 15
Princeton 14
Tokyo 14
Seoul 13
Lappeenranta 12
Salt Lake City 12
Genoa 11
Helsinki 11
Houston 11
São Paulo 11
Toronto 11
Wilmington 11
Abidjan 10
Munich 10
Brussels 9
Cambridge 9
Cangzhou 9
Florence 9
Istanbul 9
Memphis 9
Nuremberg 9
Quanzhou 9
Shanghai 9
Woodbridge 9
Wuhan 9
Baghdad 8
Denver 8
Des Moines 8
Turku 8
Brooklyn 7
Düsseldorf 7
London 7
Stockholm 7
Washington 7
Ann Arbor 6
Atlanta 6
Columbus 6
Fuzhou 6
Johannesburg 6
Palermo 6
Shenzhen 6
Bangkok 5
Bari 5
Charlotte 5
Da Nang 5
Jinan 5
Montreal 5
Padova 5
San Francisco 5
Tampa 5
Tianjin 5
Trento 5
Verona 5
Vienna 5
Andria 4
Berlin 4
Bexley 4
Catania 4
Chengdu 4
Chennai 4
Detroit 4
Dong Ket 4
Elk Grove Village 4
Friedrichshafen 4
Haiphong 4
Livorno 4
Mnichovice 4
Mumbai 4
Totale 2.416
Salva come PNG Salva come JPEG
Nome #
Chelanti del fosforo a base di ferro : quali nuovi vantaggi? = Iron-based Phosphate Binders for ESRD Patients 592
Inibitori dell’enzima prolil-idrossilasi del fattore inducibile da ipossia: una nuova terapia per l’anemia nei pazienti con insufficienza renale cronica 452
Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19 258
Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney Disease 203
Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiency 200
Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study 191
SARS‐CoV‐2–related ARDS in a maintenance hemodialysis patient : case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point‐of‐care ultrasound 182
Future treatment of vascular calcification in chronic kidney disease 179
Pro-calcifying analysis of uraemic serum from patients treated with medium cut-off membrane in a prospective, cross-over study 149
Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, Current treatments and investigational drugs 141
COVID-19 in a dialysis center in Milan from March to June 2020: understanding how to respond to the second wave of the pandemic 139
Choice of the Dialysis Modality: Practical Considerations 134
Do SGLT2 inhibitors protect elderly patients from HF rehospitalization and CKD progression? More opportunities than concerns 130
Effects of a medium cut-off (Theranova®) dialyser on haemodialysis patients: a prospective, cross-over study 127
The Role of Uremic Retention Solutes in the MIA Syndrome in Hemodialysis Subjects 126
Forced diuresis oriented by point‐of‐care ultrasound in cardiorenal syndrome type 5 due to light chain myeloma : The role of hepatic venogram: A case report 124
Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease : Results from the EQUAL Study 122
Vitamin D: are all compounds equal? 121
Efficacy and safety of etelcalcetide in hemodialysis patients with moderate to severe secondary hyperparathyroidism 120
Angiopoietin as A Novel Prognostic Marker in Kidney Disease 115
Measuring FGF23 in clinical practice: dream or reality? 113
Intrauterine life to adulthood: a potential risk factor for chronic kidney disease 111
From Physicochemical Classification to Multidimensional Insights: A Comprehensive Review of Uremic Toxin Research 103
Beyond vessels and bones: can CKD-MBD treatment improve uremic subjects' minds? 100
The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays? 91
MCO Membranes and FGF-23: Advancing Dialysis Strategies for Better Outcomes? 87
Calciprotein Particles in CKD: When Good Molecules Go Bad 84
Association between Blood Flow Measured within 30 Days from Arteriovenous Access Creation and Thrombosis Risk 77
Causal assessment of CKD-MBD biomarker alterations on CKD progression through a g-formula analysis in the EQUAL study 72
Uremic Toxin‐Driven Vascular Calcification in Chronic Kidney Disease: Molecular Pathways and Integrated Phenotypes 72
Critical evaluation of therapeutic targeting in chronic kidney disease: where do we stand 5 years on? 36
Beyond traditional roles: vitamin D and erythropoietin as immune modulators in kidney diseases 11
Vascular Calcification in Advanced Chronic Kidney Disease: Epidemiology, Pathophysiology, and Treatment 3
How are developments in the treatment armamentarium of hyperphosphatemia addressing the current therapeutic challenges? 1
Totale 4.766
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.696
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 0 0 25
2021/2022131 15 13 8 14 13 13 12 4 7 4 10 18
2022/2023302 12 6 12 35 45 72 8 14 46 3 41 8
2023/2024406 21 44 24 50 52 26 15 21 12 26 40 75
2024/20251.124 39 63 23 82 96 45 47 104 81 166 145 233
2025/20262.502 241 223 239 252 166 102 303 123 246 163 309 135
Totale 4.766